Routine first-line detection of breast cancer therapy-related cardiotoxicity by serial, fast and ultra-low-dose equilibrium radionuclide angiography.

Fiche publication

Date publication

octobre 2022

Journal

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr MARIE Pierre-Yves , Dr CLAUDIN Marine , Dr LAMBERT Aurélien

Tous les auteurs :
Decorads CE, Lambert A, Roch V, Imbert L, Perrin M, Claudin M, Salleron J, Veran N, Lamiral Z, Henneton C, Marie PY

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36289164

Résumé

This study assesses a first-line left ventricular ejection fraction (LVEF) monitoring provided by an ultra-low-dose equilibrium radionuclide angiography (ERNA) in breast cancer women treated with potentially cardiotoxic drugs and analyzes patient outcome based on the ERNA results.